Home › Companies › Treace Medical Concepts, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Treace Medical Concepts, Inc.’s Form 8-K, filed May 20, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 19, 2026: 5 items on Treace Medical Concepts, Inc.’s Form 8-K, filed May 20, 2026: 3 elected · 2 approved.
Notable dissent: 1 director (10.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Treace Medical Concepts, Inc. in the interactive database Compare manager voting policies
These tallies are Treace Medical Concepts, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 20, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Lance A. Berry | 33,804,407 | -- | -- | 820,723 | 13,516,432 | 98% | Elected | — |
| Elect Director: Elizabeth S. Hanna | 30,856,965 | -- | -- | 3,768,165 | 13,516,432 | 89% | Elected | — |
| Elect Director: Jane E. Kiernan | 33,587,226 | -- | -- | 1,037,904 | 13,516,432 | 97% | Elected | — |
| 2. Advisory Vote on Executive Compensation | 32,785,505 | 1,724,383 | 115,242 | -- | 13,516,432 | 95% | Approved | — |
| 3. Ratification of Selection of Independent Registered Public Accounting Firm | 47,885,305 | 120,733 | 135,524 | -- | 0 | 99.7% | Approved | — |
Source: Treace Medical Concepts, Inc., Form 8-K, filed with the SEC on May 20, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
114 asset managers disclosed a vote on at least one Treace Medical Concepts, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Elizabeth S. Hanna
Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Elizabeth S. Hanna”): 30,856,965 for, 3,768,165 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected, by the votes indicated below, the following nominees to the Company's Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and quali…”
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 4,273,508 for, 548,325 withheld, 24,930 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,900,754 | 0 | 3,985 | 1,888 | For |
| BlackRock | 947,383 | 0 | 0 | 0 | For |
| Fidelity | 646,998 | 0 | 0 | 1,900 | For |
| Charles Schwab | 353,805 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 0 | 0 | 0 | 174,141 | Withhold |
| Equitable | 70,086 | 0 | 0 | 39,240 | Mixed |
| TIAA | 101,049 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 73,680 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 73,672 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 68,642 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 50,000 | Withhold |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 40,814 | Withhold |
| Goldman Sachs | 39,004 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,200 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 25,830 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 24,503 | Withhold |
| Global X | 23,070 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,239 | 0 | 0 | 0 | For |
| Pacific Life | 18,331 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 16,185 | 0 | Abstain |
| Nationwide | 13,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,498 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 0 | 9,331 | Withhold |
| ProShares | 0 | 0 | 0 | 7,912 | Withhold |
| DWS | 0 | 0 | 0 | 7,338 | Withhold |
Showing the 25 largest of 39 asset managers. All 39 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jane E. Kiernan
Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Jane E. Kiernan”): 33,587,226 for, 1,037,904 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected, by the votes indicated below, the following nominees to the Company's Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and quali…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 4,712,000 for, 126,023 withheld, 8,740 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,902,647 | 0 | 3,980 | 0 | For |
| BlackRock | 947,383 | 0 | 0 | 0 | For |
| Fidelity | 648,898 | 0 | 0 | 0 | For |
| Charles Schwab | 353,805 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 174,141 | 0 | 0 | 0 | For |
| Equitable | 70,086 | 0 | 0 | 39,240 | Mixed |
| TIAA | 101,049 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 73,680 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 73,672 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 68,642 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 50,000 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 40,814 | 0 | 0 | 0 | For |
| Goldman Sachs | 39,004 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,200 | 0 | 0 | 0 | For |
| Northern Trust | 25,830 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,503 | 0 | 0 | 0 | For |
| Global X | 23,070 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,239 | 0 | 0 | 0 | For |
| Pacific Life | 18,331 | 0 | 0 | 0 | For |
| John Hancock | 16,185 | 0 | 0 | 0 | For |
| Nationwide | 13,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,498 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 0 | 9,331 | Withhold |
| ProShares | 7,912 | 0 | 0 | 0 | For |
| DWS | 7,338 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. All 39 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lance A. Berry
Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Lance A. Berry”): 33,804,407 for, 820,723 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected, by the votes indicated below, the following nominees to the Company's Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and quali…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 4,712,002 for, 126,023 withheld, 8,738 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,902,649 | 0 | 3,978 | 0 | For |
| BlackRock | 947,383 | 0 | 0 | 0 | For |
| Fidelity | 648,898 | 0 | 0 | 0 | For |
| Charles Schwab | 353,805 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 174,141 | 0 | 0 | 0 | For |
| Equitable | 70,086 | 0 | 0 | 39,240 | Mixed |
| TIAA | 101,049 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 73,680 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 73,672 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 68,642 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 50,000 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 40,814 | 0 | 0 | 0 | For |
| Goldman Sachs | 39,004 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,200 | 0 | 0 | 0 | For |
| Northern Trust | 25,830 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,503 | 0 | 0 | 0 | For |
| Global X | 23,070 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,239 | 0 | 0 | 0 | For |
| Pacific Life | 18,331 | 0 | 0 | 0 | For |
| John Hancock | 16,185 | 0 | 0 | 0 | For |
| Nationwide | 13,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,498 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 0 | 9,331 | Withhold |
| ProShares | 7,912 | 0 | 0 | 0 | For |
| DWS | 7,338 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. All 39 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 94.5% for (May 20, 2025 meeting) ▲ 0.5 pts
Description as filed by funds: APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
Treace Medical Concepts, Inc.’s own tally for this item (“2. Advisory Vote on Executive Compensation”): 32,785,505 for, 1,724,383 against — passed, per its Form 8-K filed May 20, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “By the vote stated below, the stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,906,622 | 3 | 0 | 0 | For |
| BlackRock | 947,383 | 0 | 0 | 0 | For |
| Fidelity | 648,898 | 0 | 0 | 0 | For |
| Charles Schwab | 353,805 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 174,141 | 0 | 0 | 0 | For |
| Equitable | 109,326 | 0 | 0 | 0 | For |
| TIAA | 101,049 | 0 | 0 | 0 | For |
| Dimensional | 0 | 73,680 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 73,672 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 68,642 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 50,000 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 40,814 | 0 | 0 | 0 | For |
| Goldman Sachs | 39,004 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,200 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 25,830 | 0 | 0 | Against |
| AIG/SunAmerica | 24,503 | 0 | 0 | 0 | For |
| Global X | 23,070 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,239 | 0 | 0 | 0 | For |
| Pacific Life | 18,331 | 0 | 0 | 0 | For |
| John Hancock | 16,185 | 0 | 0 | 0 | For |
| Nationwide | 13,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,498 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 9,331 | 0 | Abstain |
| ProShares | 7,912 | 0 | 0 | 0 | For |
| DWS | 7,338 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 4,675,034 for, 162,396 against, 9,331 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| CIBC Private Wealth Group LLC | 14,706,863 | 0 | 0 | 0 | For |
| BlackRock | 1,412,654 | 1,130 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 812,535 | 0 | 0 | 0 | For |
| State Street | 735,332 | 1,082 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 692,838 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 690,044 | 0 | 0 | 0 | For |
| Vanguard | 367,943 | 0 | 0 | 0 | For |
| Charles Schwab | 354,106 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 316,124 | 0 | 0 | 0 | For |
| AQR | 269,306 | 0 | 0 | 0 | For |
| Northern Trust | 1,420 | 226,132 | 0 | 0 | Against |
| Citadel | 202,439 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 200,000 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 191,228 | 0 | 0 | 0 | For |
| Nuveen | 152,434 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 148,857 | 0 | 0 | 0 | For |
| Goldman Sachs | 148,090 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 118,647 | 0 | 0 | 0 | For |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 100,000 | 0 | 0 | 0 | For |
| AllianceBernstein | 64,550 | 0 | 0 | 0 | For |
| Dimensional | 0 | 62,605 | 0 | 0 | Against |
| Point72 | 53,961 | 0 | 0 | 0 | For |
| T. Rowe Price | 51,254 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 50,000 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 33,568 | 0 | 0 | 0 | For |
Institutional-manager reports, all 88 managers: 22,127,795 for, 389,084 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Prior year: 99.9% for (May 20, 2025 meeting) ▼ 0.2 pts
Description as filed by funds: Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.
Treace Medical Concepts, Inc.’s own tally for this item (“3. Ratification of Selection of Independent Registered Public Accounting Firm”): 47,885,305 for, 120,733 against — passed, per its Form 8-K filed May 20, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “By the vote stated below, the stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 4,768,789 for, 9,331 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,906,626 | 0 | 0 | 0 | For |
| BlackRock | 947,383 | 0 | 0 | 0 | For |
| Fidelity | 648,898 | 0 | 0 | 0 | For |
| Charles Schwab | 353,805 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 174,141 | 0 | 0 | 0 | For |
| Equitable | 109,326 | 0 | 0 | 0 | For |
| TIAA | 101,049 | 0 | 0 | 0 | For |
| Dimensional | 73,680 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 73,672 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 50,000 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 40,814 | 0 | 0 | 0 | For |
| Goldman Sachs | 39,004 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,200 | 0 | 0 | 0 | For |
| Northern Trust | 25,830 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,503 | 0 | 0 | 0 | For |
| Global X | 23,070 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,239 | 0 | 0 | 0 | For |
| Pacific Life | 18,331 | 0 | 0 | 0 | For |
| John Hancock | 16,185 | 0 | 0 | 0 | For |
| Nationwide | 13,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,498 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 9,331 | 0 | Abstain |
| ProShares | 7,912 | 0 | 0 | 0 | For |
| DWS | 7,338 | 0 | 0 | 0 | For |
| SEI | 6,200 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. All 38 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 64,872,976 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.94% |
| 2 | BlackRock | 1.46% |
| 3 | Fidelity | 1.00% |
| 4 | Charles Schwab | 0.55% |
| 5 | FIRST EAGLE FUNDS | 0.27% |
| 6 | Equitable | 0.17% |
| 7 | TIAA | 0.16% |
| 8 | Dimensional | 0.11% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.11% |
| 10 | CLEARWATER INVESTMENT TRUST | 0.11% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | CIBC Private Wealth Group LLC | 22.67% |
| 2 | BlackRock | 2.18% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.25% |
| 4 | State Street | 1.14% |
| 5 | ACADIAN ASSET MANAGEMENT LLC | 1.07% |
| 6 | ARMISTICE CAPITAL, LLC | 1.06% |
| 7 | Vanguard | 0.57% |
| 8 | Charles Schwab | 0.55% |
| 9 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.49% |
| 10 | AQR | 0.42% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| John T. Treace | 12,530,959 | 19.32% | Schedule 13G, filed August 12, 2026 |
| Neil Gagnon | 6,142,107 | 9.47% | Schedule 13G, filed February 12, 2026 |
| BANK OF AMERICA CORP /DE/ | 3,533,774 | 5.45% | Schedule 13G, filed May 14, 2026 |
| BlackRock | 3,340,023 | 5.15% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 2,273,094 | 3.50% | Form 13F, quarter ended March 31, 2026 |
| State Street | 1,235,518 | 1.90% | Form 13F, quarter ended March 31, 2026 |
| Millennium Management | 1,148,115 | 1.77% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 1,010,843 | 1.56% | Form 13F, quarter ended March 31, 2026 |
| D.E. Shaw | 841,269 | 1.30% | Form 13F, quarter ended March 31, 2026 |
| Citadel Advisors | 825,575 | 1.27% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 64,872,976 shares outstanding, as reported by Treace Medical Concepts, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Treace Medical Concepts, Inc.'s shareholder meeting held May 19, 2026, in the 2025-2026 proxy season, 114 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 637 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — Treace Medical Concepts, Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Treace Medical Concepts, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 20, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Treace Medical Concepts, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Treace Medical Concepts, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Treace Medical Concepts (TMCI) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/treace-medical-concepts-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.